www.labaton.com/cases/in-re-ariad-pharmaceuticals-inc-securities-litigation

May 10, 2018 ... The defendants are ARIAD Pharmaceuticals, Inc., its Chief Executive Officer, Chief Financial Officer, Chief Medical Officer, Chief Scientific ...

www.ariadsecuritieslitigation.com

Welcome to the Settlement Website for In re ARIAD Pharmaceuticals, Inc. ... against ARIAD and the other Released Defendant Parties about the Settled Claims.

www.ariadsecuritieslitigation.com/Home/FAQ

If I do not exclude myself, can I sue Defendants or the other Released .... Settlement Class in In re ARIAD Pharmaceuticals, Inc. Securities Litigation, Case No.

www.sec.gov/Archives/edgar/data/884731/000119312516485544/d19643d10k.htm

ARIAD is a global oncology company focused on transforming the lives of cancer ...... Under one of these license agreements, Bellicum Pharmaceuticals, Inc., .... versions of imtatinib will have only a nominal impact on sales of Iclusig given ...... and to share in any amounts paid by the defendant to the government should the  ...

caselaw.findlaw.com/us-1st-circuit/1755756.html

Ariad Pharmaceuticals, Inc; Harvey J. Berger; Frank G. Haluska; Timothy P. .... On the defendants' motion, the district court dismissed the complaint in its entirety.

seekingalpha.com/symbol/ARIA

Latest Breaking news and Headlines on ARIAD Pharmaceuticals, Inc. (ARIA) stock from Seeking Alpha. Read the news as it happens!

law.justia.com/cases/federal/district-courts/FSupp/928/1279/1446761

Defendant Ariad is a Delaware corporation with its principal place of .... by Blech & Co. at nominal prices to certain defendants and unidentified others, ...... Inc., Procept Inc., Chemex Pharmaceuticals Inc., Guilford Pharmaceuticals Inc., and ...